The European Commission has adopted Implementing Regulation (EU) 2026/1118, refusing the authorization of a health claim that creatine contributes to the improvement of cognitive function. The decision follows an application submitted by Alzchem Trostberg GmbH under Regulation (EC) No 1924/2006 and is based on the scientific assessment conducted by the European Food Safety Authority (EFSA).
After reviewing the available evidence, EFSA concluded that a cause-and-effect relationship had not been established between creatine consumption and improvements in cognitive performance parameters such as memory, attention, alertness, processing speed, executive function, verbal fluency, and fluid intelligence. As a result, the health claim cannot be used in the marketing, labelling, or advertising of foods within the European Union.
Consumer News Region